15 results
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
, Asthma-COPD Overlap ... and COPD The ... ACO = asthma-COPD ... #Differences #Algorithm ... #Treatment
The goals of #COPD #treatment include recognizing the impact that both #symptoms and #exacerbations have on
The goals of #COPD ... #treatment include ... for monitoring treatment ... #management #algorithm ... #pharmacology
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
of a patients COPD ... posts for the COPD ... treatment algorithm ... Naming #Names #Pharmacology ... #Asthma
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... pulmonary disease (COPD ... #COPD #Treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... Management #Pulmonary #COPD
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... Exacerbation of COPD ... of AECOPD: • Clinical ... #AECOPD #Algorithm ... #Exacerbation #treatment
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
bronchoscopic and surgical treatments ... pulmonary disease (COPD ... patients with COPD ... are approved for clinical ... VolumeReduction #Bullectomy #Algorithm
Noninvasive Positive Pressure Ventilation (NIPPV)

Expiratory & Inspiratory Positive Airway Pressure
Both increase intrathoracic pressure, which can decrease
In COPD, decreases ... pulmonary edema) • COPD ... failure (ie.. asthma ... Aspiration - unable to clear ... hair) • Risk Of Clinical
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology ... #COPD
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
American College of Cardiology ... Task Force on Clinical ... guideline #ACCAHA2017 #cardiology ... #treatment #algorithm